AstraZeneca’s Imfinzi shows event-free survival benefit in lung cancer patients in trial
Roland Magnusson/iStock Editorial via Getty Images AstraZeneca (NASDAQ:AZN) said data from a phase 3 trial showed that Imfinzi-based therapy before ...
Tuesday, January 21, 2025
Tag: eventfree
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.